Strong Investment Portfolio Claret Capital Partners has a proven track record with over 200 SME investments across diverse sectors such as technology, life sciences, and impact investments, indicating their expertise and interest in innovative and high-growth sectors.

Recent Growth Financing The company recently invested significant capital into companies like Cinclus Pharma, SIS Medical, Deciphex, and Yseop, showcasing their active engagement in expanding their portfolio within cutting-edge tech and healthcare markets.

Industry Recognition Repeated awards as Venture Debt Provider of the Year highlight Claret Capital’s reputation and leadership in venture debt and growth financing, positioning them as a trusted partner for high-potential startups and scale-ups.

Targeted Sector Focus Their focus on technology, healthcare, and impact sectors aligns with current market trends towards innovation, digital health, and AI, offering opportunities to collaborate with forward-thinking companies and early-stage ventures.

Appealing Growth Stage Focus With a revenue range of $1M to $10M and recent large-scale investments, Claret Capital is well positioned to engage with emerging companies in the growth stage that are seeking strategic debt financing to scale their operations and technologies.